• 4Q GAAP EPS of $0.10 Per Diluted Share and Adjusted EPS of $0.19 Per Diluted Share / Full Year 2015 GAAP EPS of $0.28 Per Diluted Share and Adjusted EPS of $0.57 Per Diluted Share
  • Record 4Q Commercial Health Plan Revenue Increased 29.9% YOY / Full Year 2015 Commercial Growth of 18.8% / 18-20% growth projected for 2016
  • Revenue in 4Q, Excluding Medicare RAC, Increased by 8.6% YOY / Full Year 2015 Revenue, excluding Medicare RAC, Increased by 7.7%
  • 4Q Share Repurchases of $25 Million / Year End Shares Outstanding Down 4.5% Compared to Prior Year End

IRVING, Texas, Feb. 26, 2016 (GLOBE NEWSWIRE) -- HMS Holdings Corp. (NASDAQ:HMSY) today announced financial results for the fourth quarter and full-year 2015. Net income for the quarter ended December 31, 2015 was $8.7 million or $0.10 per diluted share, compared to net income of $6.9 million or $0.08 per diluted share in the third quarter and a loss of $2.4 million or ($0.03) per diluted share in the prior year fourth quarter. Adjusted EPS was $0.19 per diluted share in the fourth quarter, compared to $0.15 in the third quarter and $0.03 in the prior year fourth quarter. Several items negatively impacted pretax earnings in the fourth quarter of 2014 by $12.1 million or $0.07 per diluted share in adjusted EPS. In the fourth quarter of 2015 legal expense was approximately $1.4 million or $0.01 per diluted share and a lower than expected tax rate, due to a change in state apportionments and permanent differences, resulted in an after-tax benefit of approximately $0.7 million or $0.01 per diluted share.

For the full year ended December 31, 2015, net income was $24.5 million or $0.28 per diluted share, compared to $13.9 million or $0.16 per diluted share in the prior year. Adjusted EPS for the full-year 2015 increased to $0.57 per diluted share, compared to $0.41 per diluted share in full-year 2014.

Total revenue in the fourth quarter was $128.5 million, compared to total revenue of $118.4 million in the third quarter and $112.2 million in the prior year fourth quarter. For the full year 2015 total revenue increased 7.0% to $474.2 million, including $20.5 million of Medicare RAC revenue, compared to total revenue for the full year 2014 of $443.2 million, which included $22.0 million of Medicare RAC revenue.

“2015 was a breakout year for our commercial health plan business, with annual revenue up 19%. With nearly 30% year-over-year growth in the fourth quarter creating momentum and good visibility on 2016 revenue growth based on already closed sales, we are expecting commercial health plan revenue will expand again this year at a rate similar to 2015,” said Bill Lucia, HMS Chairman and CEO. “Our focus for the year ahead is on execution – implementing sold business and delighting our customers with excellent service; innovation, to stay ahead of the competition and create opportunities for new product sales; efficiency and cost reduction through process engineering; maximizing commercial health plan growth via new and expansion sales; and making an acquisition – assuming we can find the right asset at a fair price.”

Total revenue in the fourth quarter of $118.8 million, excluding Medicare RAC, was approximately 8.6% higher than the prior year fourth quarter, as a significant increase in commercial revenue was partially offset by a decline in state revenue. Commercial health plan revenue in the quarter was a record $58.5 million, a 29.9% increase compared to $45.0 million in the prior year fourth quarter and 12.5% higher than the prior quarter. State government revenue was $54.5 million in the fourth quarter, a 7.1% decrease compared to $58.7 million in the prior year fourth quarter and flat compared to the prior quarter. Non-Medicare RAC Federal and other revenue was $5.8 million in the quarter, a $0.1 million increase compared to the prior year fourth-quarter and a decline of $1.5 million from the prior quarter. Medicare RAC revenue in the quarter was $9.7 million compared to $2.8 million in the prior year fourth quarter and $4.6 million in the prior quarter.

On a full-year basis, commercial health plan revenue was $203.1 million – an 18.8% increase compared to $170.9 million in 2014; state government revenue was $226.1 million – flat compared to $225.8 million in the prior year; and non-Medicare RAC Federal and other revenue was $24.6 million – flat compared to $24.5 million in 2014. Medicare RAC revenue declined by $1.5 million for the full year to $20.5 million, compared to $22.0 million in 2014.

Coordination of benefits (COB) revenue, which continues to be our largest product line across both the government and commercial sectors, was $87.1 million in the fourth quarter compared to $81.6 million in the prior year fourth quarter, an increase of 6.7%, and it accounted for 67.8% of total revenue in the quarter, compared to 71.0% last quarter and 72.7% in the prior year fourth quarter. For the full year, COB revenue of $337.6 million increased 8% compared to $312.5 million for the full year 2014.

Payment integrity revenue (excluding Medicare RAC) was $31.7 million in the quarter, a $3.9 million or 14.0% increase from the fourth quarter of last year and a $2.0 million or 6.7% increase from the prior quarter, reflecting both the higher level of payment integrity product sales to commercial health plan customers in recent quarters and an accelerated pace of implementations due to our “ink to green” initiatives.

“Very strong cash flow gave us the capacity to buy back $50 million of our shares in the second half of 2015, while ending the year with $145.6 million in cash, an increase of $12.5 million compared to the prior year-end,” said Jeff Sherman, HMS Chief Financial Officer. “Full year 2015 revenue, excluding Medicare RAC, of $453.7 million represents an increase of 7.7% compared to the prior year and the midpoint of our expectations when we gave 2015 revenue guidance a year ago.”

The Company will provide additional 2016 guidance on its earnings conference call (details below). See also the Q4 2015 Investor Presentation which is available on the Company’s website at http://investor.hms.com/events.cfm.

Webcast and Conference Call Information

HMS will report its fourth quarter and full year 2015 financial and operating results at 7:30 AM CT / 8:30 AM ET on Friday, February 26, 2016. The webcast can be accessed via phone at (877) 303–7208 or (224) 357–2389 for international participants, or at http://investor.hms.com/events.cfm on the HMS Investor Relations website. The webcast will also be archived at http://investor.hms.com/events.cfm and will be available for replay beginning at approximately 11:00 AM CT / 12:00 PM ET on February 26, 2016. This press release and the financial statements contained herein are also available at http://investor.hms.com/releases.cfm.

The HMS Annual Report on Form 10-K for the fiscal year ended December 31, 2015 will be filed and available on the HMS website at http://investor.hms.com/financials.cfm and at www.sec.gov on February 29, 2016 and will contain additional information about our results of operations.

About HMS

HMS Holdings Corp., through its subsidiaries, provides coordination of benefits and payment integrity services for payers. The Company serves state Medicaid programs; health plans, including Medicaid managed care, Medicare Advantage and group and individual health lines of business; federal government health agencies, including the Centers for Medicare & Medicaid Services and the Veterans Health Administration; government and private employers; and other healthcare payers and sponsors, including child support agencies. As a result of the Company’s services, our customers recover billions of dollars annually and save billions more through the prevention of improper payments.

Non-GAAP Financial Measures

This press release includes presentations of earnings before interest, taxes, depreciation and amortization ("EBITDA") and adjusted EBITDA. Adjusted EBITDA represents EBITDA adjusted for stock-based compensation expense. EBITDA is a common measure of performance used by the capital markets to value enterprises, which the Company’s management uses in addition to measures calculated in accordance with generally accepted accounting principles ("GAAP") to evaluate its results of operations. EBITDA is a non-GAAP financial measure and is reconciled to net income (loss), which the Company's management believes to be the most comparable GAAP measure. Adjusted EBITDA results are calculated by adjusting GAAP income (loss) to exclude the effects of net interest expense, income taxes, depreciation and amortization and stock-based compensation expense. 

This press release also includes presentations of adjusted earnings per share ("EPS"). Adjusted EPS represents EPS adjusted for stock-based compensation expense and amortization of acquisition related software and intangible assets and for the related taxes for these adjustments. Adjusted EPS is a non-GAAP financial measure and is reconciled to EPS, which the Company’s management believes to be the most comparable GAAP measure.

The Company uses these non-GAAP financial measures for internal management purposes, when publicly providing guidance on possible future results, and as a means to evaluate period-to-period comparisons. The Company's management believes that these non-GAAP financial measures are a common measure used by its investors and analysts to evaluate its performance. The use of these non-GAAP financial measures has limitations, and the Company’s presentation of such financial measures may be different from the presentation used by other companies, and therefore comparability may be limited. These non-GAAP financial measures are used in addition to and in conjunction with results presented in accordance with GAAP and reflect an additional way of viewing aspects of the Company's operations that, when viewed with GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provides a more complete understanding of the results of operations and trends affecting the Company's business. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, income (loss) in accordance with GAAP.

Safe Harbor Statement   

This press release contains "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such statements give our projections or forecasts of future events and are based on our current expectations and assumptions regarding our business, the economy and other future conditions; they do not relate strictly to historical or current facts. Forward‐looking statements can be identified by words such as “aims,” “anticipates,” “believes,” “estimates,” “expects,” “forecasts,” “intends,” “likely,” “may,” “plans,” “projects,” “seeks,” “targets,” “will,” “would,” “could,” “should,” and similar expressions and references to guidance. In particular, these include statements relating to future actions, business plans, objectives and prospects, future operating or financial performance. Factors or events that could cause actual results to differ may emerge from time to time and it is not possible for us to predict all of them. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could differ materially from past results and those anticipated, estimated or projected. We caution you therefore against relying on any of these forward-looking statements. 

Factors that could cause or contribute to such differences, include, but are not limited to: negative or reduced growth rate of spending on Medicaid/Medicare; variations in our results of operations; our ability to execute our business plans or growth strategy; the risk that guidance may not be achieved; unfavorable outcomes in legal proceedings, including contract award protests; our ability to continue to secure contracts or favorable contract terms through the competitive bidding process; the market price of our common stock; changes in the U.S. healthcare environment or healthcare financing system and steps we take in anticipation of such changes; pending or threatened litigation; development and implementation of new product solutions or new process improvements; regulatory, budgetary or political actions that affect procurement practices; our ability to retain customers or the loss of one or more major customers; the unexpected reduction in scope or termination of a significant contract; customer dissatisfaction, our non-compliance with contractual provisions or regulatory requirements, or failure to meet performance standards triggering significant costs or liabilities under our contracts; the cancellation or delay of procurements or contract implementation due to protests or challenges to government awards; emergence of new competitors or competitors’ introduction of new or superior products or services; our failure to comply with laws and regulations governing health data or to protect such data from theft and misuse; our ability to maintain effective information and technology systems and networks, and to protect them damage, interruption or breach; our reliance on subcontractors, vendors or other third party providers and sources to perform services; restrictions on bidding or performing certain work due to perceived conflicts of interests; unanticipated changes in our effective tax rates; a failure to protect intellectual property rights, confidential and proprietary information, or confidential or proprietary information of others in our possession, despite our efforts; negative results of government or customer reviews, audits or investigations; our cash flows from operations, available cash and ability to generate sufficient cash to cover our interest and principal payments under our credit facility or to borrow or use credit; the continuation of our share repurchase program; the nature of investment and acquisition opportunities presented to us; and other factors, risks and uncertainties described in our most recent Annual Report on Form 10-K and subsequent filings with the Securities and Exchange Commission. Any forward-looking statements are made as of the date of this press release. Except as may be required by law, we disclaim any obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. 

HMS HOLDINGS CORP. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
 (in thousands, except per share amounts)
 
     Years ended December 31,
      2015   2014   2013 
Revenue    $  474,216  $  443,225  $  491,762 
Cost of services:        
Compensation      178,272     181,273     190,324 
Data processing      40,915     39,661     37,115 
Occupancy      15,766     16,950     18,397 
Direct project expenses     51,527     36,866     45,382 
Other operating expenses     28,895     24,588     26,491 
Amortization of acquisition related software      
and intangible assets     28,148     28,612     31,747 
Total cost of services     343,523     327,950     349,456 
Selling, general and administrative expenses    83,121     81,071     65,128 
Total operating expenses     426,644     409,021     414,584 
Operating income      47,572     34,204     77,178 
Interest expense      (7,812)    (7,931)    (12,460)
Interest income      49     57   71 
Other income, net      -      -    801 
Income before income taxes     39,809     26,330     65,590 
Income taxes      15,282     12,383     25,593 
Net income   $  24,527  $  13,947  $  39,997 
          
Basic income per common share:       
Net income per common share -- basic $  0.28  $  0.16  $  0.46 
Diluted income per common share:       
Net income per common share -- diluted $  0.28  $  0.16  $  0.45 
Weighted average shares:       
Basic       87,881     87,673     87,598 
Diluted        88,361     88,164     88,344 
                

Certain reclassifications were made to prior period amounts to conform to current period presentations.

  HMS HOLDINGS CORP. AND SUBSIDIARIES
  CONSOLIDATED BALANCE SHEETS
  (in thousands, except per share amounts)
           
    December 31,
         2015   2014 
  Assets        
  Current assets:       
  Cash and cash equivalents   $  145,610  $  133,116 
  Accounts receivable, net of allowance for doubtful accounts   
  of $4,849 and $4,535, respectively and estimated allowance for   
  appeals of $6,614 and $4,824, at December 31, 2015 and 2014,   
  respectively       169,146     157,101 
  Prepaid expenses       11,261     11,810 
  Prepaid income taxes       -      5,142 
  Deferred income taxes        7,460     7,811 
  Other current assets       3,051     2,639 
  Total current assets      336,528     317,619 
  Property and equipment, net      96,551     116,027 
  Goodwill        361,468     361,468 
  Intangible assets, net       54,308     74,578 
  Deferred tax assets       4,873     6,957 
  Other assets       4,329     4,339 
  Total assets    $  858,057  $  880,988 
           
  Liabilities and Shareholders' Equity     
  Current liabilities:       
  Accounts payable, accrued expenses and other liabilities $  51,661  $  54,549 
  Estimated liability for appeals      33,078     36,799 
  Income taxes payable       3,873     -  
  Total current liabilities      88,612     91,348 
  Long-term liabilities:       
  Revolving credit facility      197,796     197,796 
  Deferred tax liabilities       38,421     50,853 
  Deferred rent       6,006     5,037 
  Other liabilities       2,520     2,864 
  Total long-term liabilities      244,743     256,550 
  Total liabilities       333,355     347,898 
  Commitments and contingencies (Note 13)     
  Shareholders' equity:       
  Preferred stock -- $0.01 par value; 5,000,000 shares authorized; none   
  issued        -      -  
  Common stock -- $0.01 par value; 125,000,000 shares authorized;   
  95,263,461 shares issued and 83,989,715 shares outstanding   
  at December 31, 2015; 94,511,444 shares issued and 87,985,139 shares   
  outstanding at December 31, 2014     952     943 
  Capital in excess of par value      330,290     313,214 
  Retained earnings       288,474     263,947 
  Treasury stock, at cost: 11,273,746 and 6,526,305 shares at December 31, 2015   
  and 2014, respectively      (95,014)    (45,014)
  Total shareholders' equity      524,702     533,090 
  Total liabilities and shareholders' equity  $  858,057  $  880,988 
            

Certain reclassifications were made to prior period amounts to conform to current period presentation.

HMS HOLDINGS CORP. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
 (in thousands)
           
      Years ended December 31,
       2015   2014   2013 
Operating activities:         
Net income    $  24,527  $  13,947  $  39,997 
Adjustments to reconcile net income to net cash provided     
by operating activities:        
Depreciation and amortization of property and equipment   30,328     32,864     31,360 
Amortization of intangible assets     20,270     20,734     23,631 
Amortization of deferred financing costs     2,084     2,084     3,077 
Stock-based compensation expense     14,297     13,356     11,997 
Excess tax benefit from exercised stock options    (1,569)    (1,795)    (5,233)
Deferred income taxes      (14,020)    (12,290)    (4,354)
Loss on disposal of fixed assets     84     219     431 
Change in fair value of contingent consideration    -      (517)    35 
Changes in operating assets and liabilities:      
Accounts receivable      (12,045)   14,625     (14,956)
Prepaid expenses      549     1,132     1,341 
Prepaid income taxes      6,711     3,445     (1,559)
Other current assets      (412)    (2,150)    (172)
Other assets       10     121     28 
Income taxes payable      3,873     -      -  
Accounts payable, accrued expenses and other liabilities   (250)    18,039     1,050 
Estimated liability for appeals    (3,721)   (5,053)   14,508 
Net cash provided by operating activities    70,716     98,761     101,181 
Investing activities:         
Purchases of land, property and equipment     (8,620)    (22,687)    (22,127)
Investment in capitalized software     (3,197)    (3,514)    (3,656)
Investment in common stock      -      -      (500)
Net cash used in investing activities     (11,817)    (26,201)    (26,283)
Financing activities:         
Repayment of revolving credit facility     -      (35,000)    (95,000)
Proceeds from exercise of stock options     4,187     4,110     9,260 
Excess tax benefit from exercised stock options    1,569     1,795     5,233 
Payments of tax withholdings on behalf of employees for net-share     
settlement for stock-based compensation     (1,029)    (1,658)    (1,922)
Payments on capital lease obligations     (1,132)    (1,629)    (1,711)
Payments on contingent consideration     -      (428)    -  
Purchases of treasury stock      (50,000)    -      (25,000)
Repayment of term loan      -      -      (8,750)
Proceeds from revolving credit facility     -      -      4,046 
Payment of financing fees related to revolving credit facility   -      -      (2,915)
Net cash used in financing activities     (46,405)    (32,810)    (116,759)
Net increase (decrease) in cash and cash equivalents    12,494     39,750     (41,861)
Cash and cash equivalents at beginning of year    133,116     93,366     135,227 
Cash and cash equivalents at end of year  $  145,610  $  133,116  $  93,366 
           
Supplemental disclosure of cash flow information:      
Cash paid for income taxes   $  22,878  $  21,144  $  34,922 
Cash paid for interest    $  5,694  $  4,458  $  9,520 
           
Supplemental disclosure of noncash activities:       
Accrued property and equipment purchases  $  729  $  1,610  $  1,725 
Equipment purchased through capital leases  $  -   $  20  $  2,401 
Decrease in appeals liability for lost appeals offset with reduction     
of accounts receivable   $  7,373  $  25,706  $  7,060 
               

Certain reclassifications were made to prior period amounts to conform to current period presentation.

HMS HOLDINGS CORP. AND SUBSIDIARIES 
  (in thousands, except per share amounts) 
          
Reconciliation of Net Income (Loss) to EBITDA and Adjusted EBITDA        
          
As summarized in the following table, earnings before interest, taxes, depreciation and amortization, and stock-based compensation expense (adjusted EBITDA) was $31.1 million, for the fourth quarter of 2015,  an increase of $13.3 million or  75.1% over the same period a year ago.  Adjusted EBITDA for the year ended 2015 was  $112.5 million, an increase of $11.3 million or 11.2% year over  year.
          
 Three months ended
December 31, 		 Year ended
December 31, 		  
    
  2015   2014   2015   2014   
          
Net Income (loss)$  8,725  $  (2,394) $  24,527  $  13,947   
          
Net interest expense   1,955   1,942     7,763   7,874   
Income taxes   4,143   361     15,282   12,383   
Depreciation and amortization, net of deferred financing costs, included in net interest expense   12,143   13,567     50,598   53,598   
          
Earnings before interest, taxes, depreciation and amortization  (EBITDA)   26,966   13,476     98,170   87,802   
          
Stock based compensation expense   4,089   4,261     14,297   13,356   
Adjusted EBITDA$  31,055  $  17,737  $  112,467  $  101,158   
          
          
Reconciliation of Net Income (Loss) to GAAP EPS and Adjusted EPS         
          
As summarized in the following table, earnings per share adjusted for stock-based compensation expense and amortization of acquisitions related software and intangible assets and for the related taxes (adjusted EPS) was $0.19  for the fourth quarter of 2015, an increase of  533.3 % from $ 0.03 for the fourth quarter of 2014. Adjusted EPS for the year ended 2015 was $0.57, an increase of $0.16 or 39% for the year ended 2014.
          
 Three months ended
December 31, 		 Year ended
December 31, 		  
    
  2015   2014   2015   2014   
          
Net Income (loss)$  8,725  $  (2,394) $  24,527  $  13,947   
          
Stock-based compensation expense, net of tax   2,816   1,836     8,808   7,075   
Amortization of acquisition related software and intangible assets, net of tax   4,936   2,784     17,342   15,156   
          
Subtotal$  16,477  $  2,226  $  50,677  $  36,178   
          
Weighted average common shares, diluted 87,110   88,351   88,361   88,164   
          
Diluted GAAP EPS 0.10  $  (0.03)  0.28  $  0.16   
Diluted adjusted EPS 0.19  $  0.03   0.57  $  0.41   


Investor Contact:

Dennis Oakes
SVP, Investor Relations           
dennis.oakes@hms.com
212-857-5786

Media Contact:

Francesca Marraro
VP, Marketing and Communications
fmarraro@hms.com
212-857-5442

Primary Logo